NIMI
PTLA

Natixis Investment Managers International’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Natixis Investment Managers International’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,688
Closed -$241K – 427
2015
Q4 		$241K Hold
4,688
– – 0.03% 290
2015
Q3 		$200K Buy
4,688
+2,051
+78% +$99K 0.03% 306
2015
Q2 		$120K Buy
+2,637
New +$106K 0.01% 339

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Natixis Investment Managers International's PTLA Position: Q1 2016 in Review

Natixis Investment Managers International sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2016, closing a stake of 4,688 shares — an estimated $241K sold.

Natixis Investment Managers International first reported a position in PTLA in Q2 2015 and held it in 3 quarters. The position peaked at $241K in Q4 2015. 167 funds tracked by Wall St. Rank hold PTLA as of Q1 2016.

  • Natixis Investment Managers International reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Natixis Investment Managers International sold 4,688 Portola Pharmaceuticals, Inc. shares in Q1 2016, an estimated $241K.
  • Natixis Investment Managers International first reported a position in Portola Pharmaceuticals, Inc. in Q2 2015 and held it in 3 quarters.
  • Natixis Investment Managers International's Portola Pharmaceuticals, Inc. position peaked at $241K in Q4 2015.
  • 167 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2016.

Based on Natixis Investment Managers International's 13F filing for Q1 2016, filed 16 May 2016.